Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice
- 18 March 2005
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 328 (3) , 790-793
- https://doi.org/10.1016/j.bbrc.2004.12.091
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Vascular calcification and its relation to bone calcification: Possible underlying mechanismsJournal of Nuclear Cardiology, 2003
- Osteo/Chondrocytic Transcription Factors and Their Target Genes Exhibit Distinct Patterns of Expression in Human Arterial CalcificationArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Vascular calcification and osteoporosis: inflammatory responses to oxidized lipidsInternational Journal of Epidemiology, 2002
- Pleiotropic Effects of Statins: Lipid Reduction and BeyondJournal of Clinical Endocrinology & Metabolism, 2002
- Rationale for the role of osteoclast‐like cells in arterial calcificationThe FASEB Journal, 2002
- Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Bisphosphonates and atherosclerosisGeneral Pharmacology: The Vascular System, 2000
- In VivoEffects of Bisphosphonates on the Osteoclast Mevalonate PathwayEndocrinology, 2000
- osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcificationGenes & Development, 1998
- Immunolocalization of BMP-6, a novel TGF-β-related cytokine, in normal and atherosclerotic smooth muscle cellsAtherosclerosis, 1995